SCHEMBL6896886

SCHEMBL6896886

CC(=O)SC(C)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL668603 1.00
SCHEMBL15669276 1.00
SCHEMBL15974698 0.79 FFAR3 (0.35)
SCHEMBL16077445 0.79
SCHEMBL31323093 0.79 TP53 (0.42)
SCHEMBL7309246 0.78 TP53 (0.36)
SCHEMBL7263270 0.78 TP53 (0.36)
SCHEMBL13873968 0.78
SCHEMBL9313930 0.74
SCHEMBL19522869 0.74 TP53 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210299137-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATMENT OF DISEASES INVOLVING ACIDIC OR HYPOXIC DISEASED TISSUES CYBREXA 1, INC. 2021-09-30 US disclosed
US-10933069-B2 Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues CYBREXA 1, INC. (US) 2021-03-02 US disclosed
CN-111989137-A Compounds, compositions and methods for treating diseases involving acidic or hypoxic diseased tissue 赛博克萨1公司 2020-11-24 CN disclosed
EP-3735297-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATMENT OF DISEASES INVOLVING ACIDIC OR HYPOXIC DISEASED TISSUES Cybrexa 1, Inc. (US) 2020-11-11 EP disclosed
US-20190209580-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATMENT OF DISEASES INVOLVING ACIDIC OR HYPOXIC DISEASED TISSUES CYBREXA 1, INC. 2019-07-11 US disclosed
WO-2019136298-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATMENT OF DISEASES INVOLVING ACIDIC OR HYPOXIC DISEASED TISSUES Cybrexa, Inc. (US) 2019-07-11 WO disclosed
CN-104039356-B For chitosan targeted delivery and that small molecule integrin antagonist is covalently attached 弗·哈夫曼-拉罗切有限公司 2018-08-17 CN disclosed
EP-2750713-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF Spirogen Sàrl (CH) 2014-07-09 EP disclosed
WO-2013055987-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF SPIROGEN SÀRL (CH) 2013-04-18 WO disclosed
EP-0629627-B1 Bicyclic carboxylic acids and their derivatives as nep and aca inhibitors BRISTOL MYERS SQUIBB CO (US) 2004-05-06 EP disclosed
US-4690937-A Anti-hypertensive agents UNIVERSITY OF MIAMI (US) 1987-09-01 US disclosed
US-4690939-A Anti-hypertensive agents UNIVERSITY OF MIAMI (US) 1987-09-01 US disclosed
US-4689343-A AGRICULTURE BAYER AKTIENGESELLSCHAFT (DE) 1987-08-25 US disclosed
US-4684660-A Mercaptoacyldepeptides E. R. SQUIBB & SONS, INC. (US) 1987-08-04 US disclosed
US-4599350-A PHYTOPATHOGENS BAYER AKTIENGESELLSCHAFT (DE) 1986-07-08 US disclosed
US-4460601-A Dipeptides having a methionine residue and possessing a protective action for the liver MAGGIONI FARMACEUTICI, S.P.A. (IT) 1984-07-17 US disclosed
EP-0009898-B1 NOVEL ANTI-HYPERTENSIVE MERCAPTOACYLAMINO ACID DERIVATIVES, THEIR PREPARATION AND USE UNIVERSITY OF MIAMI (US) 1983-05-18 EP disclosed
US-4299842-A TREATMENT OF RESPIRATORY SYSTEM DISORDERS, NUCOLYTIC AGENTS CAVAZZA CLAUDIO 1981-11-10 US disclosed
EP-0038117-A1 Methods for preparing anti-hypertensive agents UNIVERSITY OF MIAMI (US) 1981-10-21 EP disclosed
EP-0009898-A1 Novel anti-hypertensive mercaptoacylamino acid derivatives, their preparation and use UNIVERSITY OF MIAMI (US) 1980-04-16 EP disclosed